Concord Biotech Ltd Dividend 2024 : Should Concord Biotech Ltd be a part of your dividend portfolio?
Concord Biotech Ltd is one of the most popular Pharmaceuticals company in the world with a market capitalisation of ₹18,002.36Cr. Its share price is ₹1,694.70 as on 25 July,2024.
The dividend is a percentage of earnings paid out to shareholders. Last year, Concord Biotech Ltd gave ₹8.75 for the full year, but should it be a part of your investments that give good dividends?
Key Highlights
Pharmaceuticals stocks do not always pay a dividend but as Concord Biotech Ltd pays dividends to reward its shareholders.
In the quarter ending March 2024, Concord Biotech Ltd has declared dividend of ₹8.75 - translating a dividend yield of 0.52%.
Let's look at Concord Biotech Ltd’s capacity to pay dividends and consider its valuation to determine its virtues as a dividend stock:
Concord Biotech Ltd’s revenue were ₹329.78Cr in the quarter ending March 2024. The revenue grew by 15.8% year on year basis since last quarter.
Concord Biotech Ltd’s profits were ₹95.02Cr in the quarter ending March 2024. The profits grew by 3.86% year on year basis since last quarter.
Concord Biotech Ltd’s dividend was ₹8.75 in the quarter ending March 2024.